Heather Rosdail
Psychiatric/Mental Health · Roseville, CANPI 1407578537
Payments from drug & device makers
Across 167 payments — averaging $49.42 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$2K
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$862
- Alkermes, Inc.$714
- Neurocrine Biosciences, Inc.$560
- AbbVie$549
- Teva Pharmaceuticals USA, Inc.$511
- plus $3K from 23 others
What the payments were for
- Food & beverage$8,254100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 38 | $2,332 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 24 | $862 |
| Alkermes, Inc. | 22 | $714 |
| Neurocrine Biosciences, Inc. | 6 | $560 |
| AbbVie | 21 | $549 |
| Teva Pharmaceuticals USA, Inc. | 5 | $511 |
| E.r. Squibb & Sons, L.L.C. | 5 | $256 |
| Alnylam Pharmaceuticals Inc. | 2 | $244 |
| Novo Nordisk | 2 | $233 |
| Otsuka America Pharmaceutical, Inc. | 10 | $213 |
| Collegium Pharmaceutical, Inc. | 4 | $177 |
| Medtronic | 1 | $145 |
| SPR Therapeutics, Inc | 1 | $133 |
| Incyte Corporation | 1 | $131 |
| Supernus Pharmaceuticals, Inc. | 7 | $123 |
| AstraZeneca | 1 | $123 |
| Averitas Pharma Inc. | 1 | $121 |
| Gilead | 1 | $115 |
| Abbott | 1 | $112 |
| Mannkind Corporation | 1 | $104 |
| Exact Sciences | 1 | $98 |
| Biogen | 1 | $94 |
| Tandem Diabetes Care, Inc. | 1 | $73 |
| Vanda Pharmaceuticals Inc. | 3 | $68 |
| Axsome Therapeutics, Inc. | 2 | $43 |
| Indivior Inc. | 2 | $43 |
| Neuronetics, Inc. | 1 | $30 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $24 |
| Janssen Scientific Affairs, LLC | 1 | $24 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SPRAVATO$1,092
- INGREZZA$494
- AMVUTTRA$244
- AJOVY$235
- INTELLIS ADAPTIVESTIM$145
- SPRINT PNS System$133
- INVEGA SUSTENNA$126
- INVEGA TRINZA$126
- UZEDY$125
- CAPLYTA$125
- JORNAY PM$125
- TEZSPIRE$123
- COBENFY$122
- Qutenza$121
- VRAYLAR$116
- Epclusa$115
- VIVITROL$114
- THORATEC HEARTMATE 3 LVAS IMPLANT KIT$112
- AFREZZA$104
How this compares
$8,254 in reported general payments places this provider in the 95th percentile of 2,433 psychiatric/mental health providers in California.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Sertraline Hcl | 13 | $46 |
Paid to pharmacies, not to this prescriber.
Other psychiatric/mental health in Roseville
- Carey MartinMillbrae$745K
- Liberty MaciasRedlands$288K
- Joshua BurgettSacramento$239K
- Jovita Ezirim-SalamialofojeLos Angeles$162K
- Angie-Kolleen TanThousand Oaks$159K
- Thy LamVista$121K
- David OhIrvine$72K
- Samantha PerkinsAnaheim$49K
- Yvette ElpidioOrange$43K
- Sarah KoLos Angeles$34K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.